Beyond Air, Inc. (NASDAQ:XAIR) Sees Significant Growth in Short Interest

Beyond Air, Inc. (NASDAQ:XAIR) was the target of a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 1,200,000 shares, an increase of 40.8% from the January 31st total of 852,200 shares. Based on an average daily volume of 1,530,000 shares, the days-to-cover ratio is presently 0.8 days.

Beyond Air Stock Down 4.0 %

Shares of NASDAQ XAIR opened at $0.26 on Tuesday. The firm has a market cap of $17.82 million, a price-to-earnings ratio of -0.24 and a beta of -0.15. Beyond Air has a 52-week low of $0.26 and a 52-week high of $1.99. The company’s 50-day simple moving average is $0.38 and its 200-day simple moving average is $0.42.

Beyond Air (NASDAQ:XAIR) last issued its earnings results on Monday, February 10th. The company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.09. Beyond Air had a negative net margin of 1,730.00% and a negative return on equity of 226.01%. During the same quarter in the prior year, the firm earned ($0.50) EPS. Equities research analysts anticipate that Beyond Air will post -0.79 EPS for the current fiscal year.

Institutional Investors Weigh In On Beyond Air

Large investors have recently added to or reduced their stakes in the business. Squarepoint Ops LLC acquired a new position in shares of Beyond Air in the 4th quarter valued at $48,000. Baldwin Wealth Partners LLC MA increased its holdings in shares of Beyond Air by 721.3% in the 4th quarter. Baldwin Wealth Partners LLC MA now owns 308,000 shares of the company’s stock valued at $110,000 after purchasing an additional 270,500 shares in the last quarter. Geode Capital Management LLC grew its stake in Beyond Air by 81.0% in the 4th quarter. Geode Capital Management LLC now owns 562,713 shares of the company’s stock valued at $202,000 after acquiring an additional 251,823 shares during the last quarter. Soros Fund Management LLC acquired a new stake in shares of Beyond Air during the 3rd quarter worth about $573,000. Finally, Balyasny Asset Management L.P. acquired a new stake in shares of Beyond Air in the fourth quarter worth approximately $1,195,000. 31.50% of the stock is owned by hedge funds and other institutional investors.

Beyond Air Company Profile

Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.